SLG-Giant Pharm, a China CRO, to Run China Arm of US National Institutes of Health (NIH) Trial
October 31, 2012 -- SLG-Giant Pharm Service Group, a China physician-owned clinical-stage CRO, was granted a full-service contract to conduct the China arm of the ATACH-II trial by the US National Institute of Health. According to SLG-Giant, this is the first NIH supported clinical trial with sites outside the US. Around the globe, ATACH-II will enroll 1200 patients. More details....